Trxade Group Achieves Record First Quarter 2016 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Trxade Group Achieves Record First Quarter 2016 Financial Results Driven by a 165% Increase in Revenues Over First Quarter 2015

First Quarter Highlights:

  • Company achieves record revenues of $1.8 million in quarter ending March 31, 2016, an increase of 165% over $696,000 in quarter ending March 31, 2015
  • Gross profit increased to $831,069 from $465,670 in quarters ending March 31, 2016 and 2015, respectively
  • Operating loss narrowed to ($372,380) from ($443,620) in the quarter ending March 31, 2016 and 2015, respectively
  • Trxade’s trading platform achieves record quarterly operating profit for 1Q16
  • As of end of 1Q16, Trxade has added over 441 independent pharmacies to its trading platform, to reach a record 5,500 members
  • Company launches HCTZ (Hydrochlorothiazide) to treat fluid edema in 1Q16

               TAMPA, Fla., April 21, 2016 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (OTCQB: TRXD), a pharmaceutical company that distributes private label pharmaceuticals through its wholly-owned subsidiary Westminster Pharmaceuticals, LLC and Trxade, Inc. a web-based market platform that enables registered independent pharmacies to quickly source and purchase pharmaceuticals, accessories and services from a wide range of manufacturers and drug distributors, today reported financial results for its first quarter, ended March 31, 2016 and provided a business update and positive outlook for 2016.

Company Produces 165% Increase in First Quarter Revenues, a New Record

Revenues for the three months ended March 31, 2016 were $1,847,151 -- an increase of 165% over $696,133 in the year-ago quarter, and 24% higher sequentially over the fourth quarter ended December 31, 2015.  The revenue growth was primarily attributable to increased wholesale pharmaceutical sales from its wholly owned subsidiary Westminster Pharmaceuticals, LLC and an increase of fee income generated from the Company’s web-based supplier-to-pharmacy trading platform ( www.trxade.com ).

For the first quarter ended March 31, 2016, the Company reported that its net loss narrowed to ($372,380), or ($0.01) per basic and diluted share, compared with a net loss of ($443,620), or ($0.01) per basic and diluted share in the year ago quarter and versus ($495,445), or ($0.02) per basic and diluted share, for the fourth quarter of 2015. 

The Company’s cost of sales was $1,016,082 and $230,463 for the quarters ending March 31, 2016 and 2015, respectively. This increase reflected a sales mix with greater revenue from wholesale pharmaceutical sales, which carries a higher cost of sales than the Company’s other revenue sources. Gross profit increased to $831,069 from $465,670 in the quarter ending March 31, 2016 and 2015, respectively.

While general and administrative expenses increased to $1,140,816 in the first quarter of 2016 compared with $908,321 in the year-ago quarter, it decreased sequentially from $1,317,412 in the fourth quarter of 2015.  Operating losses for the first quarter of 2016 narrowed to ($309,747) versus ($442,651) in the year-ago quarter, and narrowed sequentially from ($441,385) from the fourth quarter, ended December 31, 2015. 

Company Launches HCTZ (Hydrochlorothiazide) to Treat Fluid Edema in First Quarter of 2016

During the first quarter of 2016, the Company also announced that its wholly-owned subsidiary, Westminster Pharmaceuticals LLC, has launched the generic drug HCTZ (Hydrochlorothiazide) as part of an agreement with ScieGen Pharmaceuticals, Inc.  ScieGen’s ANDA Number 203018 for Hydrochlorothiazide treats fluid retention (edema) in people with congestive heart failure, cirrhosis of the liver, kidney disorders, or edema caused by taking steroids or estrogen. This medication, which is also used to treat high blood pressure (hypertension), will be marketed under the Westminster Pharmaceuticals, LLC private label.  Under the terms of the supply and distribution agreement with ScieGen, Westminster will semi-exclusively market and distribute ScieGen’s product in the United States.

CEO Sees Continuing Strong Revenue Growth and Profitability in 2016

“Our proprietary trading platform at www.trxade.com , which enables independent pharmacies to purchase drugs at an average discount of between 15%-20%, is adding new members on a monthly basis at record levels and, as a result, enabling us to experience strong top and bottom line growth across the board,” said Suren Ajjarapu, Chairman and Chief Executive Officer of Trxade Group. “Our 2016 fiscal year is off to a record start -- well ahead of our internal plan and budget -- and in-line with our primary objective of expanding our membership base while simultaneously focusing on increasing their utilization rates.  At the end of the first quarter, we reported record platform subscribers, record transactional revenue, record gross profit – along with net and operating losses both narrowing substantially in the first quarter of 2016.

“Accordingly, I am optimistic we will reach profitability in the current fiscal year as increasing pharmaceutical prices drive independent pharmacies and payors and consumers to be more aggressive in sourcing medication. In response to increasing customer demand, we are actively developing new product offerings and increased data analytics capability to add greater value by helping the independent pharmacies better manage their inventory and costs,” Mr. Ajjarapu concluded.

About Trxade Group, Inc.             Headquartered in Tampa, Florida, Trxade Group, Inc. (OTCQB: TRXD) is a pharmaceutical company that distributes private label pharmaceuticals wholesale through its wholly-owned subsidiary Westminster Pharmaceuticals, LLC and Trxade, Inc., with over 5,500 registered independent pharmacies, is a web-based market platform that enables the pharmacies to quickly source and purchase pharmaceuticals, accessories and services from a wide range of manufacturers and drug distributors. For additional information, please visit us at www.trxadegroup.com . 

Forward-Looking Statements             The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements.

Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. Except as may be required by applicable law, we assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.  The company undertakes no duty to update forward-looking statements.

Trxade Group, Inc.
Consolidated Balance Sheets
(unaudited)
   
     
  March 31, 2016 December 31, 2015
Assets    
     
Current Assets    
Cash   $ 508,279       $ 860,132    
Accounts Receivable, net     452,141         498,100    
Inventory, net     475,862         284,718    
Prepaid Assets     220,095         201,361    
Other Assets      167,509         183,359    
Total Current Assets     1,823,886         2,027,670    
     
Total Assets   $ 1,823,886       $ 2,027,670    
     
Liabilities and Shareholders’ Equity (Deficit)  
Current Liabilities    
Accounts Payable   $ 338,541       $ 356,159    
Accrued Liabilities     396,477         296,803    
     
Notes Payable net of $3,750 and $15,000 discount     246,250         235,000    
Short term Convertible Payable    
  net of $8,923 and $35,697 discount     191,077         164,303    
Total Current Liabilities     1,172,345         1,052,265    
     
Long Term Liabilities    
Convertible Note net of $220,621 and     
$241,612 discount     729,379         708,388    
Total Liabilities     1,901,724         1,760,653    
     
Shareholders’ Equity/Deficit    
Preferred Stock, $0.00001 par value; 10,000,000    
shares authorized; 0 shares issued and outstanding,    
 as of March 31, 2016 and December 31, 2015,     
 respectively     --         --    
     
Common Stock, $0.00001 par value; 100,000,000    
shares authorized; 31,435,827 and 31,435,827    
shares issued and outstanding, as of March 31, 2016     
and December 31, 2015, respectively     314         314    
     
Additional Paid-in Capital     5,943,199         5,915,674    
Retained Earnings (Deficit)     (6,021,351 )        (5,648,971 )   
Total Shareholders’ Equity (Deficit)     (77,838 )        267,017    
     
Total Liabilities and Shareholders’ Equity (Deficit)   $ 1,823,886       $ 2,027,670    

 

Trxade Group, Inc.  
Consolidated Statements of Operations  
(unaudited)  
     
  Three Months Ended March 31,  
      2016         2015      
       
Revenues   $ 1,847,151       $ 696,133      
       
Cost of Sales     1,016,082         230,463      
Gross Profit     831,069         465,670      
       
Operating Expenses      
General and Administrative     1,140,816         908,321      
       
Operating Loss     (309,747 )        (442,651 )     
       
Interest Expense     62,633         969      
       
Net Loss   $ (372,380 )      $ (443,620 )     
       
Basic loss per Common Share   $  (.01 )     $  (.01 )    
       
Diluted loss per Common Share   $  (.01 )     $  (.01 )    
       
Basic weighted average number of       
Common Shares outstanding     31,435,827         31,269,160      
       
Diluted weighted average number of       
Common Shares outstanding     31,435,827         31,269,160      
   

 

 

Investor and Media Contacts:                        Todd Markey Vice President, Investor Relations tmarkey@irpartnersinc.com Phone: 818-280-6801

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PSEG Long Island Warns Customers on QR Payment Scams

Updated Category News Views 0

Holiday panic is a thief's favorite crowbar, and Long Island households are plainly in the crosshairs. PSEG Long Island used Utility Scam Awareness Day on Nov. 18 to warn customers about impersonators demanding immediate payment under threat of a power shutoff. The central message, “Think Before You Scan,” is not flashy corporate wallpaper. It is practical advice for...

Continue Reading
LEPAS AURA Signals a Sharper Design Bet for Future Cars

Updated Category News Views 96

A porcelain-smooth concept car is not a balance sheet, but it can tell you where a young automotive brand intends to spend its attention. LEPAS unveiled AURA in October at its first Global Elegant Lifestyle Week, presenting it as the brand's first global concept car and a fresh expression of its Leopard Aesthetics design language. That matters because AURA is plainly not...

Continue Reading
Washington-to-Asia Advisory Deal Targets Policy Risk

Updated Category News Views 37

Policy bottlenecks are becoming a cost center across Southeast Asia. That is the plain-English backdrop for the strategic partnership announced November 18, 2026, by Beacon Global Strategies and Vriens & Partners. Neither firm is selling a factory, a chip design, or a new energy project. They are selling something companies increasingly cannot afford to improvise: a...

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 304

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
1095 Days Finds the Army's Long, Ordinary War Life

Updated Category News Views 89

A cracked barracks window can explain more than a polished battlefield legend. Dean R. Cherry's 1095 Days: Three Years in the Green Machine, newly released by Palmetto Publishing, puts its weight on the parts of Army life that war stories often shove into the background: cold, waiting, paperwork, arbitrary rules, lousy living conditions, and the private mental math of...

Continue Reading
Fapon’s Enzyme Push Meets Diagnostics Reality at AMP

Updated Category News Views 85

Enzymes rarely get applause at industry meetings, but they can quietly decide whether a diagnostic workflow behaves or becomes a lab headache. Fapon used its AMP 2026 appearance in Seattle to make that unglamorous case: better enzyme design may help assays move faster and keep working when samples get messy. The company wrapped up the November 10–14 meeting after...

Continue Reading
Physiatry or Orthopedics: Sorting Out Pain Care Choices

Updated Category News Views 22

Pain care gets muddled the minute people assume every ache needs the same doorway. Dr. Mala Young, a physical medicine and rehabilitation expert in Ann Arbor, Michigan, makes a useful distinction: a physiatrist and an orthopedic doctor may both see pain, mobility trouble, and injury, but they are not interchangeable. That sounds obvious until someone is staring at back...

Continue Reading
Rochester Truck Crashes Demand a Different Liability Map

Updated Category News Views 13

An 80,000-pound rig does not leave anybody the luxury of treating a wreck like a bent-fender dispute. That is the uncomfortable point behind Rochester attorney John Wright's discussion of truck crashes around I-390 and I-490. The physical damage may be obvious, but the legal story can be buried in dispatch systems, maintenance files, driver logs and corporate decisions...

Continue Reading
Lummus-Versalis Deal Adds Nine Elastomer Technologies

Updated Category News Views 56

Nine elastomer technologies do not make a flashy headline, yet this is the sort of chemical-industry move that can matter long after the applause dies down. Lummus Technology and Versalis have expanded their partnership to cover nine elastomer technologies. That is the disclosed fact, and it is meaningful on its own. The release does not lay out contract value, duration,...

Continue Reading
VeriSilicon's New AI/AR Glasses Tech: Game-Changer?

Updated Category News Views 271

VeriSilicon Unveils Next-Generation Subsystem There's some sizzle in the air with VeriSilicon's latest move in the wearable tech arena. They’ve launched a low-power, high-performance subsystem aimed squarely at AI and augmented reality glasses. Now, these gizmos aren't just the stuff of science fiction. Thanks to their Nano-XR series, reality might just get a splash...

Continue Reading

Top 5 Most Recently Viewed Articles

SK Chemicals Delivers Sustainable Innovation at ECS 2025

Updated Category News Views 484

SK Chemicals at the European Coatings Show 2025 SK chemicals has proudly participated in the European Coatings Show (ECS) 2025, marking a significant moment for the company as it engages in marketing its innovative materials. This event is known for attracting key players in the coatings and paint sector, and this year was no exception, with over 1,000 exhibitors and more...

Continue Reading
Analyzing TJX Companies' Increased Short Interest Trends

Updated Category News Views 230

Understanding the Rise in TJX Companies' Short Interest The short interest for TJX Companies (NYSE: TJX) has seen a significant uptick, now standing at 14.55 million shares sold short, which constitutes 1.29% of its float. This marks a 21.7% increase since the prior reporting period. Given the current trading volume, traders would require approximately 2.49 days to cover...

Continue Reading
IGT Expands Collaboration with La Française des Jeux for Instant Tickets

Updated Category News Views 69

IGT Expands Collaboration with La Française des Jeux Company to deliver top-performing instant ticket games to one of the world's largest lotteries International Game Technology PLC (NYSE: IGT) has officially entered a three-year partnership with La Française des Jeux (FDJ), the esteemed operator of the French National Lottery. This significant agreement follows a...

Continue Reading
Archer Expands Footprint with New Manufacturing Facility Opening

Updated Category News Views 267

Archer Expands Footprint with New Manufacturing Facility Opening New state-of-the-art facility doubles manufacturing capacity and adds more than 200 local jobs Archer, one of the fastest-growing meat snack brands in the U.S., is celebrating a significant milestone with the grand opening of its new manufacturing facility. This latest addition in Vernon, California,...

Continue Reading
Bumble Faces Downgrade from KeyBanc Amid Revenue Concerns

Updated Category News Views 309

Bumble Inc (NASDAQ: BMBL) took a hit when KeyBanc downgraded its rating from 'Overweight' to 'Sector Weight', shaking the confidence of many investors. The downgrade was more than just a simple reassessment; it became a catalyst for a stock value decline in premarket trading that had traders watching their screens with bated breath. KeyBanc Downgrade: A Harbinger of...

Continue Reading